These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 14729971)

  • 1. Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells.
    Cheng JC; Weisenberger DJ; Gonzales FA; Liang G; Xu GL; Hu YG; Marquez VE; Jones PA
    Mol Cell Biol; 2004 Feb; 24(3):1270-8. PubMed ID: 14729971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of DNA methylation and reactivation of silenced genes by zebularine.
    Cheng JC; Matsen CB; Gonzales FA; Ye W; Greer S; Marquez VE; Jones PA; Selker EU
    J Natl Cancer Inst; 2003 Mar; 95(5):399-409. PubMed ID: 12618505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methyltransferase inhibitor zebularine induces human cholangiocarcinoma cell death through alteration of DNA methylation status.
    Nakamura K; Nakabayashi K; Htet Aung K; Aizawa K; Hori N; Yamauchi J; Hata K; Tanoue A
    PLoS One; 2015; 10(3):e0120545. PubMed ID: 25799509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic insights on the inhibition of c5 DNA methyltransferases by zebularine.
    Champion C; Guianvarc'h D; Sénamaud-Beaufort C; Jurkowska RZ; Jeltsch A; Ponger L; Arimondo PB; Guieysse-Peugeot AL
    PLoS One; 2010 Aug; 5(8):e12388. PubMed ID: 20808780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer.
    Balch C; Yan P; Craft T; Young S; Skalnik DG; Huang TH; Nephew KP
    Mol Cancer Ther; 2005 Oct; 4(10):1505-14. PubMed ID: 16227399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell division is required for de novo methylation of CpG islands in bladder cancer cells.
    Velicescu M; Weisenberger DJ; Gonzales FA; Tsai YC; Nguyen CT; Jones PA
    Cancer Res; 2002 Apr; 62(8):2378-84. PubMed ID: 11956100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells.
    Billam M; Sobolewski MD; Davidson NE
    Breast Cancer Res Treat; 2010 Apr; 120(3):581-92. PubMed ID: 19459041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by zebularine on L1210 leukemia.
    Lemaire M; Momparler LF; Bernstein ML; Marquez VE; Momparler RL
    Anticancer Drugs; 2005 Mar; 16(3):301-8. PubMed ID: 15711182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methyltransferase inhibitor zebularine inhibits human hepatic carcinoma cells proliferation and induces apoptosis.
    Nakamura K; Aizawa K; Nakabayashi K; Kato N; Yamauchi J; Hata K; Tanoue A
    PLoS One; 2013; 8(1):e54036. PubMed ID: 23320119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consequences of combining siRNA-mediated DNA methyltransferase 1 depletion with 5-aza-2'-deoxycytidine in human leukemic KG1 cells.
    Vispé S; Deroide A; Davoine E; Desjobert C; Lestienne F; Fournier L; Novosad N; Bréand S; Besse J; Busato F; Tost J; De Vries L; Cussac D; Riond J; Arimondo PB
    Oncotarget; 2015 Jun; 6(17):15265-82. PubMed ID: 25948775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine in anaplastic large cell lymphoma.
    Hassler MR; Klisaroska A; Kollmann K; Steiner I; Bilban M; Schiefer AI; Sexl V; Egger G
    Biochimie; 2012 Nov; 94(11):2297-307. PubMed ID: 22687603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential response of cancer cells to zebularine.
    Cheng JC; Yoo CB; Weisenberger DJ; Chuang J; Wozniak C; Liang G; Marquez VE; Greer S; Orntoft TF; Thykjaer T; Jones PA
    Cancer Cell; 2004 Aug; 6(2):151-8. PubMed ID: 15324698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation accounts for cell adhesion-related gene silencing during 3-methylcholanthrene and diethylnitrosamine induced multistep rat lung carcinogenesis associated with overexpression of DNA methyltransferases 1 and 3a.
    Liu WB; Cui ZH; Ao L; Zhou ZY; Zhou YH; Yuan XY; Xiang YL; Liu JY; Cao J
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):70-8. PubMed ID: 21163286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells.
    Cui X; Wakai T; Shirai Y; Yokoyama N; Hatakeyama K; Hirano S
    Hum Pathol; 2006 Mar; 37(3):298-311. PubMed ID: 16613325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine reactivates epigenetically silenced genes and functions as a DNA methyltransferase inhibitor.
    Gray SG; Baird AM; O'Kelly F; Nikolaidis G; Almgren M; Meunier A; Dockry E; Hollywood D; Ekström TJ; Perry AS; O'Byrne KJ
    Int J Mol Med; 2012 Dec; 30(6):1505-11. PubMed ID: 23007409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer.
    Gnyszka A; Jastrzebski Z; Flis S
    Anticancer Res; 2013 Aug; 33(8):2989-96. PubMed ID: 23898051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic re-activation of epigenetically silenced genes by combinatorial inhibition of DNMTs and LSD1 in cancer cells.
    Han H; Yang X; Pandiyan K; Liang G
    PLoS One; 2013; 8(9):e75136. PubMed ID: 24040395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation.
    Datta J; Ghoshal K; Denny WA; Gamage SA; Brooke DG; Phiasivongsa P; Redkar S; Jacob ST
    Cancer Res; 2009 May; 69(10):4277-85. PubMed ID: 19417133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation.
    Hodge DR; Peng B; Cherry JC; Hurt EM; Fox SD; Kelley JA; Munroe DJ; Farrar WL
    Cancer Res; 2005 Jun; 65(11):4673-82. PubMed ID: 15930285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cells.
    Chiam K; Centenera MM; Butler LM; Tilley WD; Bianco-Miotto T
    PLoS One; 2011; 6(9):e25634. PubMed ID: 21980513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.